Article info

PDF

Original article
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

Authors

  1. Correspondence to Professor Désirée van der Heijde; mail{at}dvanderheijde.nl
View Full Text

Citation

van der Heijde D, Deodhar A, FitzGerald O, et al
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

Publication history

  • Received September 19, 2017
  • Revision received January 31, 2018
  • Accepted February 15, 2018
  • First published March 14, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.